Stay informed with the latest updates for the inheritable blood disorders community.

NBDF & Community
DEI - Artwork of Diverse Group of People Men Women
Kopenitz family commits substantial funding to NHF health equity…
Advocacy & Legislative
Additional Resources
Important Changes Coming to Your State Medicaid or CHIP Program
Medical
DNA Gene Helix
WFH Gene Therapy Registry Goes Live
Industry
Female Scientist Conducting Research in Lab Analyzing Data
Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM
Blood Safety
FDA Initiating National Blood Surveillance Monitoring System
NHF Responds to FDA's Proposed Blood Donation Changes
Advocacy & Legislative
NHF & HFA Respond to New Blue Cross Blue Shield of Tennessee Formularies…
Industry
Scientist Pipetting Liquids for Research
New FIX Chromogenic Assay Launched by Precision BioLogic
Industry
Biomarin Provides Hemophilia A Clinical Development Program Updates
Biomarin Provides Hemophilia A Clinical Development Program Updates
Industry
Takeda Announces Trial Results on Investigational Therapy for Ultra Rare Blood Disorder
Takeda Announces Trial Results on Investigational Therapy for…
Press Releases
NHF Announces 2023 Winter/Spring Wednesday Webinar Schedule
Industry
Image of a blue gene helix with a red section in the center
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…
Press Releases
NBDF and HFA Address Concerns on WHO's Recommendation of Cryoprecipitate
NHF Assumes Leadership of the American Plasma Users Coalition
NBDF & Community
Own Your Path
NHF's Own Your Path program begins recruitment
Industry
Clinical Trial Lab Research
Spark Announces SPK-8011 Updates at ASH
Press Releases
75th Anniversary
National Hemophilia Foundation Set to Celebrate 75 Years in 2023